Ridge Barker is a partner in the firm’s Stamford office and chair of the Corporate Finance and Securities practice group. He focuses his practice on capital market issues, corporate governance matters, asset securitizations, debt financings, general corporate and securities matters, equity compensation, partnership transactions, public reporting, public and private securities offerings, recapitalizations, spin-offs, stock and asset acquisitions and divestitures, and venture capital transactions.
Mr. Barker has broad experience in a variety of legal as well as financial, accounting and supervisory roles involving corporate finance, corporate and strategic transactions and development activities, executive compensation, operations and corporate governance. His clients include cable television operators and programmers, chemical and manufacturing companies, securities and investment advisory firms, telecommunication, biotechnology and computer companies, and other retail and industrial businesses.
Mr. Barker’s transactional work ranges from opportunity creation, investigation and development through structuring, analysis, negotiation, problem solving, closing and post-transaction implementation. He has used total quality concepts to maximize transaction values and minimize transactions costs.
Specific types of matters in which Mr. Barker has represented clients include: underwritten public and Rule 144A offerings for emerging companies, joint ventures and established companies; stock and asset acquisitions and divestitures; formation of corporations, partnerships and other entities, including broker-dealers and venture capital and investment funds; computer development and supply contracts; equity investments, restructurings, bridge loans and other transactions involving portfolio and other companies; analysis of “repo,” satellite transponder leases, television programming and other complex financial transactions; debt and equity recapitalizations and debt financings for borrowers; worldwide tax and legal restructurings and contract manufacturing programs of multinational corporations; cable television programming contracts; adoption of the first poison pill by a Connecticut bank; and internal corporate investigations.
Kelley Drye
Copyright © 2012 Kelley Drye & Warren LLP. This website contains attorney advertising. Prior results do not guarantee a similar outcome.